Attached files
| file | filename |
|---|---|
| EX-10.16 - EXHIBIT 10.16 - Zander Therapeutics, Inc | ex10_16.htm |
| EX-5.1 - EXHIBIT 5.1 - Zander Therapeutics, Inc | ex5_1.htm |
| EX-99.1 - EXHIBIT 99.1 - Zander Therapeutics, Inc | ex99_1.htm |
| EX-10.15 - EXHIBIT 10.15 - Zander Therapeutics, Inc | ex10_15.htm |
| S-1/A - FORM S-1/A - Zander Therapeutics, Inc | zander011118forms1a.htm |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use, in the statement on Form S-1 (Amendment No.1) of Zander Therapeutics, Inc., of our report dated September 5, 2017 on our audit of the financial statements of Zander Therapeutics, Inc. as of June 30, 2017 and June 30, 2016, and the related statements of operations, stockholders’ equity and cash flows for the years ended June 30, 2017 and June 30, 2016, and the reference to us under the caption “Experts”.
/s/ AMC Auditing
AMC Auditing
Las Vegas, Nevada
January 10, 2018